Table 3.
Summary of reported incidence rate
| Ref | Author | Year | Location | ESRD patients | Sample | Incidence rate | Follow-up time |
|---|---|---|---|---|---|---|---|
| 23 | Shakuntala | 1992 | UAE/Abudhabi | 96 | NR | 73.6 pmp | 14 year |
| 24 | El-Reshaid | 1994 | Kuwait | 647 | NR | 72 pmp | 4.5 year |
| 59 | Mitwalli | 1995 | KSA/South-Gizan | 124 | 654685 | 189.4 pmp | 7 month |
| 26 | Al-Homrany | 1998 | KSA/South-Asir | 114 | NR | 214.9 pmp | 6 year |
| 27 | Subermanian | 2001 | KSA/South-Gizan | NR | 172446 | *7.44% | 13 year |
| 29 | Al-Khunaizi | 2003 | KSA/East-Dhahran | 37 | 250000 | 148 pmp | 4 year |
| 64 | Al-Khunaizi | 2007 | KSA/East-Dhahran | 12 | 95 | **13% | 7 year |
| 59 | Mitwalli | 1995 | KSA/West-Madinah | 54 | 828477 | 65.2 pmp | 7 month |
| 61 | Mohamed | 2004 | KSA/West-Madinah | 106 | NR | 137.5 pmp | 1 year |
* The mean of annual growth rate
** This estimation based on single study per 100 population
NR = not reported, PMP - per million population